Seelos Therapeutics, Inc. (SEELQ) — Net Asset Quality Index
Seelos Therapeutics, Inc. (SEELQ) has a Net Asset Quality Index of -1181.6% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.38 Million minus total liabilities of $30.51 Million yields net assets of $-28.13 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore balance sheet size of Seelos Therapeutics, Inc. for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Seelos Therapeutics, Inc. Net Asset Quality Index Over Time (2020–2023)
This chart shows how Seelos Therapeutics, Inc.'s Net Asset Quality Index has evolved across 4 annual periods from 2020 to 2023. As of June 2024, the index stands at -1181.6%, representing net assets of $-28.13 Million against total assets of $2.38 Million USD. See Seelos Therapeutics, Inc. (SEELQ) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Seelos Therapeutics, Inc. (2020–2023)
The table below presents the year-by-year Net Asset Quality Index for Seelos Therapeutics, Inc. from 2020 to 2023, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Seelos Therapeutics, Inc. market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | -618.5% | $-33.51 Million | $5.42 Million | $38.93 Million | ▼ -571.8 pp |
| 2022 | -46.6% | $-10.61 Million | $22.75 Million | $33.36 Million | ▼ -115.3 pp |
| 2021 | 68.7% | $57.32 Million | $83.50 Million | $26.18 Million | ▲ +53.9 pp |
| 2020 | 14.7% | $2.57 Million | $17.49 Million | $14.92 Million | — |